Southern blotting, also known as nucleic transfer blotting, is a technique employed to detect specific DNA and RNA sequences in biological samples such as bacteria, viruses, and human genomic DNA. It allows detection of these nucleic acid fingerprints through the use of radioactive or non-radioactive probes that are designed to bind to the targeted sequences. The technique finds wide application in medical diagnostic procedures such as detection of genetic disorders, identification of novel pathogens, screening for antibiotic resistant strains, forensic analysis, and cancer research.
The global Southern blotting market is estimated to be valued at US$ 3.23 billion in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased adoption in medical diagnostic procedures is expected to be a major driver for the southern blotting market during the forecast period. The technique helps in rapidly identifying genetic mutations that can cause diseases. It plays a crucial role in diagnosing diseases like cancer, cystic fibrosis, and hemophilia. It is also used to diagnose sexually transmitted infections as it can detect microorganisms like bacteria and viruses. Growing burden of diseases like cancer and genetic disorders worldwide has increased the demand for diagnostic solutions, thereby providing an impetus to the southern blotting market. According to World Health Organization (WHO), cancer burden is expected to reach 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. These trends are proving conducive for increased adoption of southern blotting.
Strength: Southern blotting offers high specificity and sensitivity for detecting nucleic acid sequences. It is considered as a gold standard technique for DNA fingerprinting.
Weakness: Southern blotting technique is time-consuming and labour-intensive. It requires large amount of nucleic acid samples and radioactive probes.
Opportunity: Growing application of southern blotting technique in research areas such as genetics, molecular biology and forensic science is creating new avenues for market growth.
Threats: Availability of advanced molecular techniques like PCR and microarrays poses significant threat to southern blotting market. Shift towards automated platforms also challenges conventional southern blotting systems.
The Global Southern Blotting Market Size is expected to witness high growth over the forecast period of 2024 to 2031. The global Southern blotting market is estimated to be valued at US$ 3.23 billion in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.
The Asia Pacific region holds maximum potential for southern blotting market during the forecast period. Counties like China, Japan and India are expected to spearhead the market growth owing to increasing healthcare spending, rising life science research activities and expanding diagnostics industry. North America and Europe are established markets for southern blotting while Latin America and Middle East & Africa offer untapped opportunities.
Key players operating in the Southern blotting market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. These players are focusing on new product launches and strategic collaborations to enhance their market share. For instance, in 2022 Mitsubishi Chemical Foods Corporation launched an advanced southern blotting system with automated capabilities.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it